"Prevalence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
| Descriptor ID |
D015995
|
| MeSH Number(s) |
E05.318.308.985.525.750 N01.224.935.597.750 N06.850.505.400.975.525.750 N06.850.520.308.985.525.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prevalence".
Below are MeSH descriptors whose meaning is more specific than "Prevalence".
This graph shows the total number of publications written about "Prevalence" by people in this website by year, and whether "Prevalence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 6 | 6 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 12 | 12 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 14 | 14 |
| 2002 | 0 | 14 | 14 |
| 2003 | 0 | 18 | 18 |
| 2004 | 0 | 22 | 22 |
| 2005 | 0 | 20 | 20 |
| 2006 | 0 | 32 | 32 |
| 2007 | 0 | 30 | 30 |
| 2008 | 0 | 43 | 43 |
| 2009 | 0 | 29 | 29 |
| 2010 | 0 | 28 | 28 |
| 2011 | 0 | 51 | 51 |
| 2012 | 0 | 47 | 47 |
| 2013 | 0 | 36 | 36 |
| 2014 | 0 | 48 | 48 |
| 2015 | 0 | 41 | 41 |
| 2016 | 0 | 45 | 45 |
| 2017 | 0 | 56 | 56 |
| 2018 | 0 | 63 | 63 |
| 2019 | 0 | 53 | 53 |
| 2020 | 0 | 67 | 67 |
| 2021 | 0 | 45 | 45 |
| 2022 | 0 | 26 | 26 |
| 2023 | 0 | 22 | 22 |
| 2024 | 0 | 29 | 29 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prevalence" by people in Profiles.
-
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
-
Prevalence of unnecessary kidney function exclusion criteria in urologic oncology clinical trials. Urol Oncol. 2024 Dec; 42(12):452.e15-452.e19.
-
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders. JAMA Psychiatry. 2024 Oct 01; 81(10):976-984.
-
Editors' Note: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations. Neurology. 2024 Oct 22; 103(8):e209893.
-
Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2024 Sep 03; 7(9):e2434704.
-
Clinical characteristics and functioning of adults with bipolar I disorder: Evidence from the mental and substance use disorders prevalence study. J Affect Disord. 2024 Dec 01; 366:317-325.
-
Clinical presentation and factors associated with gluten exposure in children with celiac disease. J Pediatr Gastroenterol Nutr. 2024 Oct; 79(4):895-904.
-
Prevalence of suicidal and self-harm ideation in fathers during the perinatal and early parenting period: A systematic review and meta-analysis. Aust N Z J Psychiatry. 2024 Dec; 58(12):1020-1033.
-
Prevalence of faculty mentoring programs in anesthesiology and medical schools in the US and their association with federal research funding. J Clin Anesth. 2024 Oct; 97:111558.
-
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy. Obstet Gynecol. 2024 Sep 01; 144(3):411-420.